Tags

Type your tag names separated by a space and hit enter

Federal travel restrictions to prevent disease transmission in the United States: An analysis of requested travel restrictions.
Travel Med Infect Dis. 2017 Jul - Aug; 18:30-35.TM

Abstract

BACKGROUND

Individuals with certain communicable diseases may pose risks to the health of the traveling public; there has been documented transmission on commercial aircraft of tuberculosis (TB), measles, and severe acute respiratory syndrome (SARS). Federal public health travel restrictions (PHTR) prevent commercial air or international travel of persons with communicable diseases that pose a public health threat.

METHODS

We described demographics and clinical characteristics of all cases considered for PHTR because of suspected or confirmed communicable disease from May 22, 2007, to December 31, 2015.

RESULTS

We reviewed 682 requests for PHTR; 414 (61%) actions were completed to place 396 individuals on PHTR. The majority (>99%) had suspected (n = 27) or confirmed (n = 367) infectious pulmonary TB; 58 (16%) had multidrug-resistant-TB. There were 128 (85%) interceptions that prevented the initiation or continuation of travel. PHTR were removed for 310 (78%) individuals after attaining noninfectious status and 86 (22%) remained on PHTR at the end of the analysis period.

CONCLUSIONS

PHTR effectively prevent exposure during commercial air travel to persons with potentially infectious diseases. In addition, they are effective tools available to public health agencies to prevent commercial travel of individuals with certain communicable diseases and possibly reconnect them with public health authorities.

Links

PMC Free PDF
PMC Free Full Text
Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Jungerman MR
Quarantine and Border Health Services, Division of Global Migration and Quarantine, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: Guk8@cdc.gov.
Vonnahme LA
Quarantine and Border Health Services, Division of Global Migration and Quarantine, US Centers for Disease Control and Prevention, Atlanta, GA, United States; United States Public Health Service, Washington, DC, United States. Electronic address: kdy1@cdc.gov.
Washburn F
Quarantine and Border Health Services, Division of Global Migration and Quarantine, US Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: Wlz5@cdc.gov.
Alvarado-Ramy F
Quarantine and Border Health Services, Division of Global Migration and Quarantine, US Centers for Disease Control and Prevention, Atlanta, GA, United States; United States Public Health Service, Washington, DC, United States. Electronic address: Fba8@cdc.gov.

MeSH

AdolescentAdultAgedAged, 80 and overChildFemaleHumansInfection ControlMaleMiddle AgedPublic HealthTravelTravel MedicineUnited StatesYoung Adult

Pub Type(s)

Journal Article

Language

eng

PubMed ID

28648932

Citation

Jungerman, M Robynne, et al. "Federal Travel Restrictions to Prevent Disease Transmission in the United States: an Analysis of Requested Travel Restrictions." Travel Medicine and Infectious Disease, vol. 18, 2017, pp. 30-35.
Jungerman MR, Vonnahme LA, Washburn F, et al. Federal travel restrictions to prevent disease transmission in the United States: An analysis of requested travel restrictions. Travel Med Infect Dis. 2017;18:30-35.
Jungerman, M. R., Vonnahme, L. A., Washburn, F., & Alvarado-Ramy, F. (2017). Federal travel restrictions to prevent disease transmission in the United States: An analysis of requested travel restrictions. Travel Medicine and Infectious Disease, 18, 30-35. https://doi.org/10.1016/j.tmaid.2017.06.007
Jungerman MR, et al. Federal Travel Restrictions to Prevent Disease Transmission in the United States: an Analysis of Requested Travel Restrictions. Travel Med Infect Dis. 2017 Jul - Aug;18:30-35. PubMed PMID: 28648932.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Federal travel restrictions to prevent disease transmission in the United States: An analysis of requested travel restrictions. AU - Jungerman,M Robynne, AU - Vonnahme,Laura A, AU - Washburn,Faith, AU - Alvarado-Ramy,Francisco, Y1 - 2017/06/23/ PY - 2017/01/25/received PY - 2017/06/19/revised PY - 2017/06/21/accepted PY - 2017/6/27/pubmed PY - 2017/10/21/medline PY - 2017/6/27/entrez KW - Restrictions KW - Travel KW - Tuberculosis SP - 30 EP - 35 JF - Travel medicine and infectious disease JO - Travel Med Infect Dis VL - 18 N2 - BACKGROUND: Individuals with certain communicable diseases may pose risks to the health of the traveling public; there has been documented transmission on commercial aircraft of tuberculosis (TB), measles, and severe acute respiratory syndrome (SARS). Federal public health travel restrictions (PHTR) prevent commercial air or international travel of persons with communicable diseases that pose a public health threat. METHODS: We described demographics and clinical characteristics of all cases considered for PHTR because of suspected or confirmed communicable disease from May 22, 2007, to December 31, 2015. RESULTS: We reviewed 682 requests for PHTR; 414 (61%) actions were completed to place 396 individuals on PHTR. The majority (>99%) had suspected (n = 27) or confirmed (n = 367) infectious pulmonary TB; 58 (16%) had multidrug-resistant-TB. There were 128 (85%) interceptions that prevented the initiation or continuation of travel. PHTR were removed for 310 (78%) individuals after attaining noninfectious status and 86 (22%) remained on PHTR at the end of the analysis period. CONCLUSIONS: PHTR effectively prevent exposure during commercial air travel to persons with potentially infectious diseases. In addition, they are effective tools available to public health agencies to prevent commercial travel of individuals with certain communicable diseases and possibly reconnect them with public health authorities. SN - 1873-0442 UR - https://www.unboundmedicine.com/medline/citation/28648932/full_citation L2 - https://linkinghub.elsevier.com/retrieve/pii/S1477-8939(17)30110-2 DB - PRIME DP - Unbound Medicine ER -